Y-mAbs Therapeutics, Inc. (YMAB) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Y-mAbs Therapeutics, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-11.69
Burn Risk
P/B Ratio
3.77
Strong
WeakModerateStrong
Earnings Yield
-8.55%
Yield Gap
Profitability Health
2024Return on Equity
-32.24%
Weak
WeakModerateStrong
Operating Margin
-35.58%
Weak
WeakModerateStrong
Net Profit Margin
-33.83%
Weak
WeakModerateStrong
Growth Indicators
2024Revenue Growth
3.38%
Weak
WeakModerateStrong
Net Income Growth
-38.45%
Weak
WeakModerateStrong
EPS Growth
-36.73%
Weak
WeakModerateStrong
Efficiency & Liquidity
2024Current Ratio
4.16
Strong
WeakModerateStrong
Quick Ratio
3.85
Strong
WeakModerateStrong
Asset Turnover
0.73x
Moderate
WeakModerateStrong
Inventory Turnover
2.11x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-4.53%
Weak
WeakModerateStrong
EV / Free Cash Flow
-17.86x
Strong
WeakModerateStrong
Net Debt / EBITDA
2.17x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.955
Strong
WeakModerateStrong
Return on Invested Capital
-32.06%
Weak
WeakModerateStrong
Cash Conversion Cycle
95.16 days
Weak
WeakModerateStrong
Fortress screener guardrails
0/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for YMAB.
View Financial Statements